142 filings
8-K
MRTX
Mirati Therapeutics Inc
23 Jan 24
Contingent Value Rights Agreement
8:48am
8-K
MRTX
Mirati Therapeutics Inc
19 Dec 23
Other Events
7:30am
8-K
MRTX
Mirati Therapeutics Inc
13 Dec 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
MRTX
Mirati Therapeutics Inc
24 Nov 23
Other Events
4:45pm
8-K
MRTX
Mirati Therapeutics Inc
13 Nov 23
Other Events
12:00am
8-K
mcf8ua jpakbx1rxqd6
6 Nov 23
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
8:05am
8-K
v0u04ov0
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
8-K
owxj 2hdxvhaabd
23 Aug 23
Mirati Therapeutics Announces Departure of Chief Financial Officer Laurie Stelzer
4:01pm
8-K
yrubnn ap
9 Aug 23
Mirati Therapeutics Announces Proposed Public Offering
4:40pm
8-K
t3l7p64wd8d649aaz5
8 Aug 23
Mirati Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
4:01pm
8-K
k4v6310a8oam351lw7j
21 Jul 23
Other Events
6:05am
8-K
e9x 9uzj8
23 Jun 23
Departure of Directors or Certain Officers
4:02pm
8-K
jqemjm ww
24 May 23
Other Events
4:09pm
8-K
t872fgld
12 May 23
Departure of Directors or Certain Officers
4:02pm
8-K
nob4ikddcr83z
9 May 23
Mirati Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Updates
4:06pm
8-K
q4wyxwzky73
28 Feb 23
Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
4:08pm
8-K
n2764v
9 Jan 23
Results of Operations and Financial Condition
1:06pm
8-K
nms50te3bjxwy1aof5nu
12 Dec 22
Other Events
8:22pm
8-K
bb9sw 7gyd9ek
5 Dec 22
Other Events
7:00pm
8-K
q6njwlhefv fqko
2 Dec 22
Mirati Therapeutics Announces Update for the Phase 3 SAPPHIRE Study
8:01am